Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Pharmacovigilance and Risk Management Strategies Conference
Session 9: Considerations for Medication Error Pharmacovigilance
Session Chair(s)
Jo Wyeth, PharmD
- Postmarket Safety Program Lead, DMEPA, OMEPRM, OSE, CDER
- FDA, United States
Medication errors have a significant public health burden. This session will discuss the impact of medication errors, current state of medication error pharmacovigilance, and propose directions for building a pharmacovigilance medication error program for the future.
Learning Objective :
At the conclusion of this session, participants should be able to:
- Recognize that medication error prevention requires a collaborative effort among regulators, industry, patients, healthcare providers, and other stakeholders
- Identify differences and challenges in the approach for medication error pharmacovigilance versus adverse event pharmacovigilance
- Describe current and emerging approaches for surveilling medication errors
Speaker(s)
Medication Errors: Impact on the Victims
Christina Michalek, RPh
- Medication Safety Specialist
- Institute for Safe Medication Practices , United States
Speaker
Reema Mehta, PharmD, MPH
- Senior Director, Head of Risk Management and Safety Surveillance Research
- Pfizer Inc, United States
Roadmap for Medication Error Pharmacovigilance
Jo Wyeth, PharmD
- Postmarket Safety Program Lead, DMEPA, OMEPRM, OSE, CDER
- FDA, United States
Natural Language Processing and Machine Learning with Patient Safety Event Reports
Allan Fong, MS
- Research Scientist and Data Scientist
- MedStar Institute for Innovation National Center for Human Factors in Healthcare, United States
Panelist
Lubna Merchant, PharmD, MS
- Deputy Office Director, OMEPRM, OSE, CDER
- FDA, United States
Contact us
Registration Questions?
Preconference Short Courses
Short Course 1: Pharmacovigilance and Risk Management Planning
Short Course 2: Interdisciplinary Safety Evaluation During Product Development
Short Course 3: Reference Safety Information
Short Course 4: Introduction to Statistics in Pharmacovigilance
Short Course 5: Pharmacovigilance for Medication Errors
On Demand Content Preview Webinar
Preparing for PV Inspections – Beyond the Basics
Download eBook
Pharmacovigilance and Risk Management in 2020: A Global Perspective